Protein-truncating or rare missense variants in coding regions of CHEK2, especially 1100delC (rs555607708), have been previously reported to have moderate penetrance for overall breast cancer risk and ER + breast cancer in familial studies [60] and population based studies [61–63]. This evidence concerns the gene CHEK2 and breast cancer.